documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
70 rows where agency_id = "FDA" and document_type = "Notice" sorted by comment_end_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
agency_id 1
- FDA · 70 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date ▲ | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-N-0131-0001 | FDA | FDA-2026-N-0131 | FDA Rare Disease Innovation Hub Future Programming; Request for Comments | Notice | Request for Comments | 2026-01-30 | 2026 | 1 | 2026-01-30 | 2027-01-01 | 2026-03-22 09:00:09 | 2026-01903 | 1 | 0 | 09000064b91893ee |
| FDA-2016-D-1280-0005 | FDA | FDA-2016-D-1280 | Electronic Submission of Postmarketing Individual Case Safety Reports to the Food and Drug Administration Adverse Event Monitoring System Using International Council of Harmonisation E2B(R3) Data Standards; Regional Data Elements and Implementation Schedule | Notice | Announcement | 2026-04-06 | 2026 | 4 | 2026-04-06 | 2026-10-02 | 2026-04-07 09:00:25 | 2026-06660 | 1 | 0 | 09000064b9253dbc |
| FDA-2025-E-2426-0006 | FDA | FDA-2025-E-2426 | Determination of Regulatory Review Period for Purposes of Patent Extension; BLUJEPA | Notice | Determinations | 2026-02-13 | 2026 | 2 | 2026-02-13 | 2026-08-13 | 2026-02-13 20:03:13 | 2026-02901 | 1 | 0 | 09000064b91aa6fb |
| FDA-2025-E-0152-0006 | FDA | FDA-2025-E-0152 | Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY | Notice | Determinations | 2026-02-06 | 2026 | 2 | 2026-02-06 | 2026-08-06 | 2026-02-06 20:05:43 | 2026-02388 | 1 | 0 | 09000064b919467e |
| FDA-2025-E-0153-0006 | FDA | FDA-2025-E-0153 | Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY | Notice | Determinations | 2026-02-06 | 2026 | 2 | 2026-02-06 | 2026-08-06 | 2026-02-06 20:06:34 | 2026-02388 | 1 | 0 | 09000064b919467f |
| FDA-2024-E-3539-0006 | FDA | FDA-2024-E-3539 | Determination of Regulatory Review Period for Purposes of Patent Extension; BEQVEZ | Notice | Determinations | 2026-02-06 | 2026 | 2 | 2026-02-06 | 2026-08-06 | 2026-02-14 13:19:52 | 2026-02387 | 1 | 0 | 09000064b9195b4d |
| FDA-2025-E-0154-0006 | FDA | FDA-2025-E-0154 | Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY | Notice | Determinations | 2026-02-06 | 2026 | 2 | 2026-02-06 | 2026-08-06 | 2026-02-06 20:07:01 | 2026-02388 | 1 | 0 | 09000064b9195c17 |
| FDA-2026-N-3273-0001 | FDA | FDA-2026-N-3273 | Financial Transparency and Efficiency of the Prescription Drug User Fee Act, Biosimilar User Fee Act, and Generic Drug User Fee Amendments; Public Meeting; Request for Comments | Notice | Request for Comments | 2026-04-15 | 2026 | 4 | 2026-04-15 | 2026-07-24 | 2026-04-15 17:05:22 | 2026-07248 | 1 | 0 | 09000064b9282224 |
| FDA-2023-N-0119-0020 | FDA | FDA-2023-N-0119 | Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for Comments | Notice | Request for Comments | 2026-02-27 | 2026 | 2 | 2026-02-27 | 2026-07-11 | 2026-04-14 09:00:18 | 2026-03961 | 1 | 0 | 09000064b91e326c |
| FDA-2026-N-2366-0001 | FDA | FDA-2026-N-2366 | Commissioner’s National Priority Voucher (CNPV) Pilot Program; Public Hearing; Request for Comments | Notice | Request for Comments | 2026-03-23 | 2026 | 3 | 2026-03-23 | 2026-06-30 | 2026-04-12 09:00:14 | 2026-05573 | 1 | 0 | 09000064b922c21a |
| FDA-2026-N-2742-0001 | FDA | FDA-2026-N-2742 | Agency Information Collection Activities; Proposed Collection; Comment Request; Color Additive Certification | Notice | 60 Day Proposed Information Collection | 2026-04-10 | 2026 | 4 | 2026-04-10 | 2026-06-10 | 2026-04-10 18:01:37 | 2026-06936 | 1 | 0 | 09000064b926825a |
| FDA-2026-N-2743-0001 | FDA | FDA-2026-N-2743 | Agency Information Collection Activities; Proposed Collection; Comment Request; Submission of Petitions: Food Additive, Color Additive (Including Labeling), Submission of Information to a Master File in Support of Petitions; and Electronic Submission Using Food and Drug Administration Form 3503 | Notice | 60 Day Proposed Information Collection | 2026-04-10 | 2026 | 4 | 2026-04-10 | 2026-06-10 | 2026-04-10 18:22:24 | 2026-06935 | 1 | 0 | 09000064b926821b |
| FDA-2026-N-2915-0001 | FDA | FDA-2026-N-2915 | Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Approval of Medical Devices | Notice | 60 Day Proposed Information Collection | 2026-04-10 | 2026 | 4 | 2026-04-10 | 2026-06-10 | 2026-04-10 17:47:50 | 2026-06906 | 1 | 0 | 09000064b9268328 |
| FDA-2026-N-2431-0001 | FDA | FDA-2026-N-2431 | Agency Information Collection Activities; Proposed Collection; Comment Request; Administrative Practices and Procedures; Formal Hearings | Notice | 60 Day Proposed Information Collection | 2026-04-07 | 2026 | 4 | 2026-04-07 | 2026-06-09 | 2026-04-14 19:40:33 | 2026-06719 | 1 | 0 | 09000064b9255485 |
| FDA-2025-E-0863-0006 | FDA | FDA-2025-E-0863 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:37:03 | 2026-06478 | 1 | 0 | 09000064b924cccb |
| FDA-2025-E-0845-0006 | FDA | FDA-2025-E-0845 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:34:01 | 2026-06478 | 1 | 0 | 09000064b924dac3 |
| FDA-2025-E-0866-0006 | FDA | FDA-2025-E-0866 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:42:13 | 2026-06478 | 1 | 0 | 09000064b924ccce |
| FDA-2025-E-0372-0005 | FDA | FDA-2025-E-0372 | Determination of Regulatory Review Period for Purposes of Patent Extension; ZIIHERA | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:52:42 | 2026-06476 | 1 | 0 | 09000064b924da88 |
| FDA-2025-E-3074-0006 | FDA | FDA-2025-E-3074 | Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:57:30 | 2026-06480 | 1 | 0 | 09000064b924c470 |
| FDA-2025-E-0871-0006 | FDA | FDA-2025-E-0871 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:49:10 | 2026-06478 | 1 | 0 | 09000064b924c46e |
| FDA-2025-E-3073-0006 | FDA | FDA-2025-E-3073 | Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:55:54 | 2026-06480 | 1 | 0 | 09000064b924da86 |
| FDA-2025-E-3626-0006 | FDA | FDA-2025-E-3626 | Determination of Regulatory Review Period for Purposes of Patent Extension; ENFLONSIA | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:59:57 | 2026-06479 | 1 | 0 | 09000064b924d98d |
| FDA-2025-E-0870-0006 | FDA | FDA-2025-E-0870 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:48:07 | 2026-06478 | 1 | 0 | 09000064b924c46d |
| FDA-2026-N-2740-0001 | FDA | FDA-2026-N-2740 | Agency Information Collection Activities; Proposed Collection; Comment Request; Customer/Partner Customer Service Satisfaction Surveys | Notice | 60 Day Proposed Information Collection | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:29:44 | 2026-06482 | 1 | 0 | 09000064b924dac4 |
| FDA-2025-E-0868-0006 | FDA | FDA-2025-E-0868 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:44:23 | 2026-06478 | 1 | 0 | 09000064b924c0e1 |
| FDA-2025-E-0865-0006 | FDA | FDA-2025-E-0865 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:39:45 | 2026-06478 | 1 | 0 | 09000064b924cccd |
| FDA-2025-E-1672-0007 | FDA | FDA-2025-E-1672 | Determination of Regulatory Review Period for Purposes of Patent Extension; ENCELTO | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 18:06:28 | 2026-06477 | 1 | 0 | 09000064b924d940 |
| FDA-2014-E-2328-0006 | FDA | FDA-2014-E-2328 | Determination of Regulatory Review Period for Purposes of Patent Extension; INJECTAFER | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 18:09:13 | 2026-06483 | 1 | 0 | 09000064b924d4f5 |
| FDA-2025-E-0864-0006 | FDA | FDA-2025-E-0864 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:38:27 | 2026-06478 | 1 | 0 | 09000064b924cccc |
| FDA-2025-E-0872-0006 | FDA | FDA-2025-E-0872 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:50:02 | 2026-06478 | 1 | 0 | 09000064b924c46f |
| FDA-2025-E-0867-0006 | FDA | FDA-2025-E-0867 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:43:31 | 2026-06478 | 1 | 0 | 09000064b924c0e0 |
| FDA-2025-E-0158-0006 | FDA | FDA-2025-E-0158 | Determination of Regulatory Review Period for Purposes of Patent Extension; HYMPAVZI | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 18:04:00 | 2026-06481 | 1 | 0 | 09000064b924d942 |
| FDA-2025-E-0869-0006 | FDA | FDA-2025-E-0869 | Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY | Notice | Determinations | 2026-04-03 | 2026 | 4 | 2026-04-03 | 2026-06-03 | 2026-04-03 17:45:32 | 2026-06478 | 1 | 0 | 09000064b924ba07 |
| FDA-2026-N-0809-0001 | FDA | FDA-2026-N-0809 | Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments | Notice | Request for Comments | 2026-03-03 | 2026 | 3 | 2026-03-03 | 2026-06-02 | 2026-04-13 09:00:28 | 2026-04196 | 1 | 0 | 09000064b91ed501 |
| FDA-2026-N-2476-0001 | FDA | FDA-2026-N-2476 | Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products; Request for Information and Comments | Notice | Request for Comments | 2026-03-31 | 2026 | 3 | 2026-03-31 | 2026-06-02 | 2026-04-10 09:00:28 | 2026-06184 | 1 | 0 | 09000064b92439d6 |
| FDA-2024-E-5140-0006 | FDA | FDA-2024-E-5140 | Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM | Notice | Determinations | 2025-11-24 | 2025 | 11 | 2025-11-24 | 2026-05-27 | 2026-01-24 13:16:48 | 2025-20667 | 1 | 0 | 09000064b908e3f0 |
| FDA-2024-E-5139-0006 | FDA | FDA-2024-E-5139 | Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM | Notice | Determinations | 2025-11-24 | 2025 | 11 | 2025-11-24 | 2026-05-27 | 2026-01-24 13:16:48 | 2025-20667 | 1 | 0 | 09000064b908e3ef |
| FDA-2024-E-5141-0006 | FDA | FDA-2024-E-5141 | Determination of Regulatory Review Period for Purposes of Patent Extension; ENVISION MAMMOGRAPHY PLATFORM | Notice | Determinations | 2025-11-24 | 2025 | 11 | 2025-11-24 | 2026-05-27 | 2026-01-24 13:16:50 | 2025-20667 | 1 | 0 | 09000064b9092f99 |
| FDA-2024-E-5681-0006 | FDA | FDA-2024-E-5681 | Determination of Regulatory Review Period for Purposes of Patent Extension; ALTIUS DIRECT ELECTRICAL NERVE STIMULATION SYSTEM | Notice | Determinations | 2025-11-24 | 2025 | 11 | 2025-11-24 | 2026-05-27 | 2025-11-24 19:32:14 | 2025-20668 | 1 | 0 | 09000064b9093521 |
| FDA-2026-N-2365-0001 | FDA | FDA-2026-N-2365 | Agency Information Collection Activities; Proposed Collection; Comment Request; Reporting Associated With Animal Drug and Animal Generic Drug User Fees | Notice | 60 Day Proposed Information Collection | 2026-03-23 | 2026 | 3 | 2026-03-23 | 2026-05-23 | 2026-03-23 17:37:47 | 2026-05620 | 1 | 0 | 09000064b922c25e |
| FDA-2026-N-2364-0001 | FDA | FDA-2026-N-2364 | Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Advisory Committees | Notice | 60 Day Proposed Information Collection | 2026-03-23 | 2026 | 3 | 2026-03-23 | 2026-05-23 | 2026-03-25 09:00:29 | 2026-05623 | 1 | 0 | 09000064b922c187 |
| FDA-2026-N-1849-0001 | FDA | FDA-2026-N-1849 | Agency Information Collection Activities; Proposed Collection; Comment Request; Premarket Notifications Submission | Notice | 60 Day Proposed Information Collection | 2026-03-19 | 2026 | 3 | 2026-03-19 | 2026-05-19 | 2026-03-19 17:24:48 | 2026-05329 | 1 | 0 | 09000064b9224334 |
| FDA-2026-N-2279-0001 | FDA | FDA-2026-N-2279 | Preparation for International Cooperation on Cosmetics Regulation Twentieth Annual Meeting (ICCR–20); Request for Comments | Notice | Request for Comments | 2026-03-18 | 2026 | 3 | 2026-03-18 | 2026-05-19 | 2026-04-03 09:00:22 | 2026-05280 | 1 | 0 | 09000064b922165c |
| FDA-2026-N-1736-0001 | FDA | FDA-2026-N-1736 | Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements | Notice | 60 Day Proposed Information Collection | 2026-03-13 | 2026 | 3 | 2026-03-13 | 2026-05-13 | 2026-03-13 17:05:05 | 2026-04938 | 1 | 0 | 09000064b92145ad |
| FDA-2025-N-4731-0052 | FDA | FDA-2025-N-4731 | Increasing Access to Nonprescription Drugs; Public Meeting; Request for Comments | Notice | Request for Comments | 2026-04-15 | 2026 | 4 | 2026-04-15 | 2026-05-09 | 2026-04-15 17:08:45 | 2026-07335 | 1 | 0 | 09000064b9282192 |
| FDA-2025-E-0493-0006 | FDA | FDA-2025-E-0493 | Determination of Regulatory Review Period for Purposes of Patent Extension; ENSACOVE | Notice | Determinations | 2026-03-06 | 2026 | 3 | 2026-03-06 | 2026-05-06 | 2026-03-06 19:06:30 | 2026-04491 | 1 | 0 | 09000064b91f8458 |
| FDA-2026-N-2741-0001 | FDA | FDA-2026-N-2741 | Consideration of Acceptable Market Name Change for Certain Rockfish (Sebastes spp.); Request for Information | Notice | Requests for Information (RFI) | 2026-04-01 | 2026 | 4 | 2026-04-01 | 2026-05-02 | 2026-04-14 19:40:35 | 2026-06294 | 1 | 0 | 09000064b924995a |
| FDA-2026-N-1867-0001 | FDA | FDA-2026-N-1867 | Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—New Drug Application 220359, for Camizestrant Tablets; Supplemental New Drug Application (sNDA) 218197/S–004, for Truqap (Capivasertib) Tablets | Notice | Request for Comments | 2026-03-09 | 2026 | 3 | 2026-03-09 | 2026-04-30 | 2026-04-16 09:00:12 | 2026-04497 | 1 | 0 | 09000064b9200842 |
| FDA-2026-N-0686-0001 | FDA | FDA-2026-N-0686 | Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements | Notice | 60 Day Proposed Information Collection | 2026-02-24 | 2026 | 2 | 2026-02-24 | 2026-04-28 | 2026-02-24 19:45:30 | 2026-03589 | 1 | 0 | 09000064b91d5809 |
| FDA-2024-E-3572-0007 | FDA | FDA-2024-E-3572 | Determination of Regulatory Review Period for Purposes of Patent Extension; TEVIMBRA | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:52:55 | 2026-03851 | 1 | 0 | 09000064b91deb48 |
| FDA-2025-E-0161-0006 | FDA | FDA-2025-E-0161 | Determination of Regulatory Review Period for Purposes of Patent Extension; ORLYNVAH | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:55:38 | 2026-03848 | 1 | 0 | 09000064b91deb09 |
| FDA-2024-E-3565-0006 | FDA | FDA-2024-E-3565 | Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:38:14 | 2026-03855 | 1 | 0 | 09000064b91e03ee |
| FDA-2024-E-3555-0007 | FDA | FDA-2024-E-3555 | Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:35:08 | 2026-03855 | 1 | 0 | 09000064b91dec48 |
| FDA-2025-E-1226-0007 | FDA | FDA-2025-E-1226 | Determination of Regulatory Review Period for Purposes of Patent Extension; AEROPACE | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:32:36 | 2026-03849 | 1 | 0 | 09000064b91dec81 |
| FDA-2025-E-1229-0006 | FDA | FDA-2025-E-1229 | Determination of Regulatory Review Period for Purposes of Patent Extension; MERIT MEDICAL WRAPSODY | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:43:12 | 2026-03853 | 1 | 0 | 09000064b91e03f1 |
| FDA-2025-E-0371-0006 | FDA | FDA-2025-E-0371 | Determination of Regulatory Review Period for Purposes of Patent Extension; REVUFORJ | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:46:51 | 2026-03847 | 1 | 0 | 09000064b91dec08 |
| FDA-2024-E-3564-0006 | FDA | FDA-2024-E-3564 | Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:36:56 | 2026-03855 | 1 | 0 | 09000064b91e03ed |
| FDA-2025-E-0500-0006 | FDA | FDA-2025-E-0500 | Determination of Regulatory Review Period for Purposes of Patent Extension; TRYNGOLZA | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-26 20:57:25 | 2026-03850 | 1 | 0 | 09000064b91deac5 |
| FDA-2025-E-1228-0006 | FDA | FDA-2025-E-1228 | Determination of Regulatory Review Period for Purposes of Patent Extension; MERIT MEDICAL WRAPSODY | Notice | Determinations | 2026-02-26 | 2026 | 2 | 2026-02-26 | 2026-04-28 | 2026-02-27 10:00:26 | 2026-03853 | 1 | 0 | 09000064b91dec45 |
| FDA-2026-N-0027-0001 | FDA | FDA-2026-N-0027 | Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing | Notice | 60 Day Proposed Information Collection | 2026-02-25 | 2026 | 2 | 2026-02-25 | 2026-04-28 | 2026-02-25 19:16:33 | 2026-03773 | 1 | 0 | 09000064b91da53a |
| FDA-2026-N-0496-0001 | FDA | FDA-2026-N-0496 | Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds | Notice | 60 Day Proposed Information Collection | 2026-02-25 | 2026 | 2 | 2026-02-25 | 2026-04-28 | 2026-04-03 09:00:19 | 2026-03772 | 1 | 0 | 09000064b91da591 |
| FDA-2023-P-3942-1120 | FDA | FDA-2023-P-3942 | Labeling and Preventing Cross-Contact of Gluten for Packaged Foods; Request for Information | Notice | Requests for Information (RFI) | 2026-01-22 | 2026 | 1 | 2026-01-22 | 2026-04-23 | 2026-04-16 09:00:08 | 2026-01121 | 1 | 0 | 09000064b91781b1 |
| FDA-2026-N-0746-0001 | FDA | FDA-2026-N-0746 | Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program | Notice | 60 Day Proposed Information Collection | 2026-02-20 | 2026 | 2 | 2026-02-20 | 2026-04-22 | 2026-03-14 09:00:11 | 2026-03326 | 1 | 0 | 09000064b91c75af |
| FDA-2026-N-1305-0001 | FDA | FDA-2026-N-1305 | Agency Information Collection Activities; Proposed Collection; Comment Request; New Animal Drugs for Minor Use and Minor Species | Notice | 60 Day Proposed Information Collection | 2026-02-20 | 2026 | 2 | 2026-02-20 | 2026-04-22 | 2026-04-06 09:00:14 | 2026-03353 | 1 | 0 | 09000064b91c750d |
| FDA-2026-N-0499-0001 | FDA | FDA-2026-N-0499 | Agency Information Collection Activities; Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice | Notice | 60 Day Proposed Information Collection | 2026-02-20 | 2026 | 2 | 2026-02-20 | 2026-04-22 | 2026-02-20 20:23:05 | 2026-03332 | 1 | 0 | 09000064b91c75b1 |
| FDA-2026-N-1303-0001 | FDA | FDA-2026-N-1303 | Agency Information Collection Activities; Proposed Collection; Comment Request; Adverse Events Associated With New Animal Drugs | Notice | 60 Day Proposed Information Collection | 2026-02-20 | 2026 | 2 | 2026-02-20 | 2026-04-22 | 2026-02-20 20:55:00 | 2026-03352 | 1 | 0 | 09000064b91c3035 |
| FDA-2026-N-0684-0001 | FDA | FDA-2026-N-0684 | Agency Information Collection Activities; Proposed Collection; Comment Request; Approved Organizations for Wholesale Drug Distributors and Third-Party Logistics Providers | Notice | 60 Day Proposed Information Collection | 2026-02-20 | 2026 | 2 | 2026-02-20 | 2026-04-22 | 2026-02-20 20:51:55 | 2026-03333 | 1 | 0 | 09000064b91c307f |
| FDA-2026-N-0497-0001 | FDA | FDA-2026-N-0497 | Agency Information Collection Activities; Proposed Collection; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions | Notice | 60 Day Proposed Information Collection | 2026-02-18 | 2026 | 2 | 2026-02-18 | 2026-04-21 | 2026-02-18 19:12:13 | 2026-03094 | 1 | 0 | 09000064b91b8f13 |
| FDA-2026-N-0498-0001 | FDA | FDA-2026-N-0498 | Agency Information Collection Activities; Proposed Collection; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products | Notice | 60 Day Proposed Information Collection | 2026-02-19 | 2026 | 2 | 2026-02-19 | 2026-04-21 | 2026-02-19 20:20:32 | 2026-03311 | 1 | 0 | 09000064b91bd409 |
| FDA-2025-E-0862-0006 | FDA | FDA-2025-E-0862 | Determination of Regulatory Review Period for Purposes of Patent Extension; SYMVESS | Notice | Determinations | 2026-02-19 | 2026 | 2 | 2026-02-19 | 2026-04-21 | 2026-02-19 20:54:45 | 2026-03312 | 1 | 0 | 09000064b91bd33f |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT,
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date);
CREATE INDEX idx_docs_withdrawn ON documents(withdrawn);
document_type 1